[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"daytime-sleepiness\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:daytime-sleepiness":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100546457","whole-food-plant-based-diet-effect-on-obstructive-sleep-apnea-100546457",false,"NCT06395181","Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea","Effect of Whole Food Plant-based Diet in Patients With Obstructive Sleep Apnea","Inclusion Criteria:\n\n* Daytime sleepiness with ESS score ≥ 5.\n* Patient's prior sleep study with AHI between ≥ 10 and ≤ 45 (4% scoring criterion).\n* On treatment for OSA, failed or not willing to use all other OSA treatment options\n* Has access to a weight scale at home or able to come into the Sleep Clinic to be weighed after the 8-week plant-based diet period.\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* Current use of a vegan diet.\n* BMI ≤ 22.\n* Complex, central sleep apnea.\n* Pre-existing significant degree of cardio-pulmonary disease-heart failure with reduced EF of 35 or lower, unstable arrythmia, severe degree of pulmonary hypertension, severe degree of obstructive or restrictive lung disease including COPD and Interstitial lung disease.\n* On weight loss medications or starting new exercise regimen during the 8-week plant-based diet period.","ALL","18 Years","70 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This research aims to develop a better understanding and clinical knowledge of the effects of a plant based diet on severity and daytime sleepiness in Obstructive Sleep Apnea.",[27,28],"Obstructive Sleep Apnea","Daytime Sleepiness","RECRUITING","2026-03-26",{"date":32,"type":33},"2026-03-31","ACTUAL",{"date":35,"type":33},"2024-05-14",{"date":37,"type":21},"2026-05",{"name":39,"class":40},"Mayo Clinic","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":63,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":41},"100539611","promoting-teenage-sleep-for-improved-mental-health-and-school-performance-100539611","NCT06306092","Promoting Teenage Sleep for Improved Mental Health and School Performance","Promoting Teenage Sleep - for Better Mental Health and School Performance","TeenSleep","Inclusion Criteria:\n\nStudents in Swedish high schools and upper secondary schools.\n\nExclusion Criteria:\n\n\\-",true,"13 Years","19 Years",{"count":54,"type":21},3000,[24],"The overall aim of this project is to evaluate the effectiveness of two school-based programs that have the potential to promote adolescent sleep and prevent future depressive symptoms. The programs will be offered to students aged 13-19 at Swedish high schools and upper secondary schools at the classroom level. The students will be compared to teaching as usual (control group).",[58,59,60,61,28,62],"Mental Health Issue","Insomnia","Depression","Anxiety","Wellness, Psychological",[64,65,66,67],"Sleep","Mental health","Adolescents","School-based intervention","2026-03-03",{"date":70,"type":33},"2026-03-05",{"date":72,"type":33},"2024-08-17",{"date":74,"type":21},"2030-06-30",{"name":76,"class":40},"Kristianstad University",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":50,"sex":16,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":4,"studyType":22,"phases":88,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":41},"100616886","sleep-and-morning-wellbeing-study-100616886","NCT07311434","Sleep and Morning Wellbeing Study","Evaluation of Perceived Outcomes With AGZ: A Randomized, Controlled, Consumer Perception Study","Inclusion Criteria:\n\n* Male or female.\n* Age 25-59 years.\n* BMI ≥18.5 and ≤29.9 kg\u002Fm².\n* Currently experiencing issues with sleep quality, falling asleep, staying asleep, or waking during the night.\n* RU-SATED score ≤17.\n* Willing and able to follow the study protocol.\n* Willing to discontinue any other supplements (including nootropics, adaptogens, calming herbs), medications, herbal remedies, or over-the-counter sleep medications (e.g., zolpidem, diphenhydramine, Benadryl, ZzzQuil, Unisom, magnesium or melatonin products) used to assist with sleep during the study.\n* Agree to limit alcohol intake within approximately 4 hours of bedtime throughout participation.\n* Agree to limit caffeine intake to ≤400 mg\u002Fday (about 3-4 cups of coffee) and avoid ingestion of caffeine-containing products after 2:00 PM during the study period.\n* Generally healthy and not living with any uncontrolled chronic disease.\n* Resides in the United States.\n* Willing to discontinue any restricted products and adhere to all required study assessments.\n\nExclusion Criteria:\n\n* Diagnosed chronic sleep conditions (e.g., insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, sleep apnea).\n* Current use of sleep-tracking technology (e.g., wrist-worn trackers, rings, smartphone apps) that could influence sleep behavior or perception.\n\nWomen currently undergoing perimenopause or experiencing vasomotor symptoms (e.g., night sweats).\n\n* Use of hormone therapy (estrogen, progesterone, phytoestrogens) within the last 3 months.\n* Diagnosed psychiatric disorders including major depressive disorder with acute symptoms, bipolar disorder, generalized anxiety disorder with active symptoms, and PTSD with frequent nightmares.\n* Diagnosed neurodegenerative or chronic pain disorders, including Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia.\n* Regular prescribed stimulant use (e.g., amphetamines such as Adderall\u002FVyvanse; methylphenidate such as Ritalin\u002FConcerta; modafinil\u002Farmodafinil).\n* Current use of CNS-activating antidepressants (bupropion, fluoxetine, venlafaxine, sertraline).\n* Current or recent use of cannabis or THC-containing products (recreational or medicinal marijuana, CBD with measurable THC, synthetic cannabinoids) within the past 30 days.\n* Employment in jobs disrupting nighttime sleep (e.g., night shift, rotating shift, excessive travel).\n* Current use of prescription sleep aids.\n* Introduction of any new sleep-related supplements, medications, herbal remedies, or melatonin products during the study.\n* Use of any prescription or OTC products with sedative properties (e.g., melatonin, diphenhydramine, doxylamine, valerian, ZzzQuil, Advil PM) within 4 weeks prior to enrollment or habitual use ≥3 times per week prior to enrollment unless investigator-approved.\n* Allergy or sensitivity to any study product ingredients.\n* Pregnant, breastfeeding, or trying to conceive during the study period.\n* History of substance abuse.\n* Heavy alcohol use (≥8 drinks\u002Fweek for women or ≥15 drinks\u002Fweek for men).\n* Participation in another research study now or within the next 7 weeks.\n* Any condition or behavior that, in the investigator's judgment, may interfere with study participation or data integrity.","22 Years","59 Years",{"count":87,"type":21},300,[24],"The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.",[64,91,92,28],"Relaxation","Stress","2026-02-10",{"date":95,"type":33},"2026-02-11",{"date":97,"type":33},"2026-01-20",{"date":99,"type":21},"2026-06-01",{"name":101,"class":102},"Athletic Greens International","INDUSTRY"]